A detailed history of Lido Advisors, LLC transactions in Viatris Inc stock. As of the latest transaction made, Lido Advisors, LLC holds 25,019 shares of VTRS stock, worth $315,739. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,019
Previous 739,140 96.62%
Holding current value
$315,739
Previous $7.86 Million 96.31%
% of portfolio
0.0%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.32 - $12.13 $7.37 Million - $8.66 Million
-714,121 Reduced 96.62%
25,019 $290,000
Q2 2024

Aug 14, 2024

BUY
$10.05 - $12.02 $7.3 Million - $8.74 Million
726,817 Added 5898.05%
739,140 $7.86 Million
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $6,254 - $7,509
-555 Reduced 4.31%
12,323 $147,000
Q4 2023

Feb 14, 2024

SELL
$8.77 - $10.85 $48,375 - $59,848
-5,516 Reduced 29.99%
12,878 $139,000
Q3 2023

Nov 14, 2023

SELL
$9.59 - $11.35 $167,825 - $198,625
-17,500 Reduced 48.75%
18,394 $181,000
Q2 2023

Aug 09, 2023

BUY
$9.02 - $10.29 $64,826 - $73,954
7,187 Added 25.04%
35,894 $358,000
Q1 2023

May 15, 2023

BUY
$9.2 - $12.26 $264,104 - $351,947
28,707 New
28,707 $276,000
Q4 2021

Feb 15, 2022

SELL
$12.09 - $14.68 $186,149 - $226,027
-15,397 Closed
0 $0
Q3 2021

Feb 15, 2022

SELL
$13.25 - $15.13 $1.35 Million - $1.54 Million
-101,807 Reduced 86.86%
15,397 $208,000
Q3 2021

Nov 12, 2021

BUY
$13.25 - $15.13 $1.35 Million - $1.54 Million
101,542 Added 648.33%
117,204 $208,000
Q2 2021

Aug 12, 2021

SELL
$12.97 - $16.15 $51 - $64
-4 Reduced 0.03%
15,662 $224,000
Q1 2021

May 13, 2021

SELL
$13.59 - $18.54 $24,896 - $33,965
-1,832 Reduced 10.47%
15,666 $219,000
Q4 2020

Feb 08, 2021

BUY
$14.3 - $18.74 $250,221 - $327,912
17,498 New
17,498 $327,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.3B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.